TITLE

Drugs in Depressive Illness

AUTHOR(S)
Hussain, Zulfiquar
PUB. DATE
May 1970
SOURCE
British Medical Journal;5/23/1970, Vol. 2 Issue 5707, p482
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64096905

 

Related Articles

  • Sex and depression. Lever, Janet; Schwartz, Pepper // Glamour;Sep95, Vol. 93 Issue 9, p80 

    Reports on the link between sex and depression. Estimated number of Americans suffering from depressive illness; Treatment for depression; Drugs that can cause sexual dysfunction; Lack of interest and enjoyment in sex among depressed women.

  • A Brief Introduction to a NEW GLOBAL EPIDEMIC. Sparks, John // Newsweek (Pacific Edition);6/21/2004 (Pacific Edition), Vol. 143 Issue 25, p44 

    Offers a look at the rise of depressive mental illnesses as a global health problem and presents a number of charts and graphs dealing with depression. Types of depression including unipolar major depression, dysthymic disorder and bipolar disorder; Factors that trigger depression; Treatment of...

  • A Brief Introduction to a NEW GLOBAL EPIDEMIC. Sparks, John // Newsweek (Atlantic Edition);6/21/2004 (Atlantic Edition), Vol. 143 Issue 25, p58 

    Offers a look at the rise of depressive mental illnesses as a global health problem and presents a number of charts and graphs dealing with depression. Types of depression including unipolar major depression, dysthymic disorder and bipolar disorder; Factors that trigger depression; Treatment of...

  • Aripiprazole: A Viewpoint by Michel Bourin. Bourin, Michel // CNS Drugs;2004, Vol. 18 Issue 6, p377 

    Comments on the novel antipsychotic drug aripiprazole. Applications in treating manic-depressive illnesses; Efficacy; Tolerability and product safety.

  • By the way...Even GPs misunderstand depression. Martin Scurr // Daily Mail;11/24/2015, p46 

    MISUNDERSTANDING about the nature of depression, and about antidepressant drugs, means many people with this serious illness are failing to receive proper treatment.

  • Synaptic Peacekeeping: Of Bipolar and Securitization. Liebert, Rachel // Women's Studies Quarterly;Fall/Winter2010, Vol. 38 Issue 3/4, p325 

    An essay is presented on manic-depressive illness. The representation of the illeness in advertising of drugs by the pharmaceutical industry is considered, as is the change in terminology in medical literature to describe the illness as "bipolar disorder." The name change for the illness is...

  • Depression, anxiety, and confusion. Barraclough, Jennifer // BMJ: British Medical Journal (International Edition);11/22/97, Vol. 315 Issue 7119, p1365 

    Discusses the diagnosis and treatment of depression, anxiety and delirium. Risk factors for anxiety and depression; Common causes of organic mental disorders; Symptoms and signs of depression and anxiety; Prevention and management of the illnesses; Psychotropic drugs; Psychological and...

  • Anhedonia: exclusion from the pleasure dome. Snaith, Philip // BMJ: British Medical Journal (International Edition);7/18/92, Vol. 305 Issue 6846, p134 

    Focuses on the concept importance of anhedonia in identifying certain forms of depression. Pathogenic features of depressive illnesses; Development of depression subscale' Clinical symptoms of anhedonia; Ability of an anhedonia state to respond to antidepressant drugs.

  • Rxs to treat mental illnesses flowing through the pipeline. Conlan, Michael F. // Drug Topics;5/6/96, Vol. 140 Issue 9, p86 

    Reports on incoming drugs in the United States for the treatment of mental illnesses. Role of pharmaceutical companies in brain research; Insight into mental illnesses; Drugs approved for obsessive-compulsive disorder, bipolar disorder and depression.

  • Users call for antidepressant ban to be extended to new adult patients. Leason, Katie // Community Care;6/26/2003, Issue 1478, p18 

    Focuses on the use of the antidepressant drug Seroxat in treating depressive illness in Great Britain. Side effects of the drug; Result of the trials on the effect of the drug; Remarks from Seroxat Users' Group chairperson Sarah Venn on the drug.

Share

Read the Article

Other Topics